STOCK TITAN

Alpha Cognition to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Alpha Cognition Inc. (TSX-V:ACOG, OTCQB:ACOGF), a biopharmaceutical company focused on neurodegenerative disorders, will present at the Planet MicroCap Showcase: VEGAS 2023 on April 26, 2023, at 10:30 AM PST. CEO Michael McFadden will lead the presentation and answer questions afterward. Interested investors can attend live via webcast or schedule one-on-one meetings at the conference in Las Vegas. Alpha Cognition is developing ALPHA-1062, a new treatment aimed at Alzheimer's disease, designed to minimize gastrointestinal side effects. Further details can be found on the Planet MicroCap website.

Positive
  • None.
Negative
  • None.

VANCOUVER, BC / ACCESSWIRE / April 5, 2023 / Alpha Cognition Inc. (TSX-V:ACOG)(OTCQB:ACOGF), a biopharmaceutical company developing novel therapies for debilitating neurodegenerative disorders, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 at 10:30AM (Local Time -PST). Michael McFadden, CEO of Alpha Cognition, will be hosting the presentation and answering questions at the conclusion.

To access the live presentation, please use the following information:

Planet MicroCap Showcase: VEGAS 2023
Date: Wednesday, April 26th, 2023
Time: 1:30 PM Eastern Time (10:30 AM Pacific Time)
Webcast: https://www.webcaster4.com/Webcast/Page/2963/47987

If you would like to book 1x1 investor meetings with Alpha Cognition, and to attend the Planet MicroCap Showcase: VEGAS 2023, please make sure you are registered here: https://planetmicrocapshowcase.com/signup

1x1 meetings will be scheduled and conducted in person at the conference venue in LAS VEGAS.

The Planet MicroCap Showcase: VEGAS 2023 website is available here:
https://planetmicrocapshowcase.com/

If you can't make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Agenda": https://planetmicrocapshowcase.com/agenda

News Compliments of Accesswire

About Alpha Cognition

Alpha Cognition Inc. is a clinical stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Amyotrophic Lateral Sclerosis (ALS), for which there are limited treatment options.

ALPHA-1062, is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062's active metabolite is differentiated from donepezil and rivastigmine in that it binds neuronal nicotinic receptors, most notably the alpha-7 subtype, which is known to have a positive effect on cognition. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer's dementia, and as an intranasal formulation for traumatic brain injury.

About Planet MicroCap

Planet MicroCap is a global multimedia financial news, publishing and events company focused on news dissemination, providing information, data and analytics for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space.

If you would like to attend the Planet MicroCap Showcase, please register here: https://planetmicrocapshowcase.com/signup

Contact:
info@alphacognition.com
https://www.alphacognition.com/

SOURCE: Alpha Cognitionvia SNN Network



View source version on accesswire.com:
https://www.accesswire.com/747130/Alpha-Cognition-to-Present-at-the-Planet-MicroCap-Showcase-VEGAS-2023-on-Wednesday-April-26-2023-1x1-Meetings-on-Thursday-April-27-2023

FAQ

What is Alpha Cognition scheduled to present at Planet MicroCap Showcase: VEGAS 2023?

Alpha Cognition will present on April 26, 2023, at 10:30 AM PST.

Who will lead the presentation for Alpha Cognition?

CEO Michael McFadden will host the presentation.

How can I attend Alpha Cognition's presentation at Planet MicroCap Showcase?

You can join the live presentation via webcast using the link provided in the press release.

What is ALPHA-1062 being developed for?

ALPHA-1062 is aimed at treating Alzheimer's disease with expected minimal gastrointestinal side effects.

When is the one-on-one investor meetings scheduled with Alpha Cognition?

One-on-one meetings will take place on April 27, 2023, at the conference venue in Las Vegas.

ALPHA COGNITION INC NEW

OTC:ACOGF

ACOGF Rankings

ACOGF Latest News

ACOGF Stock Data

35.66M
149.58M
Biotechnology
Healthcare
Link
United States of America
Vancouver